Sort
53,477 grants matching “addiction”
NIDA Clinical Trials Network: Greater New York Node
$1,445,101John P Rotrosen · New York University School Of Medicine · UG1 · FY2016 · DA
Opioid use disorders: UF Pharmacy medications discovery and development
$1,444,681Lance R McMahon · University Of Florida · UH3 · FY2021 · DA
Opioid use disorders: UF Pharmacy medications discovery and development
$1,444,681Christopher R McCurdy · University Of Florida · UH3 · FY2023 · DA
Opioid use disorders: UF Pharmacy medications discovery and development
$1,444,681Christopher R McCurdy · University Of Florida · UH3 · FY2022 · DA
New approaches to addiction treatment
$1,444,376David Epstein · National Institute On Drug Abuse · ZIA · FY2019 · DA
New approaches to addiction treatment
$1,444,105David Epstein · National Institute On Drug Abuse · ZIA · FY2018 · DA
Endocannabinoid Active Sites as Therapeutic Targets
$1,444,077Alexandros Makriyannis · Northeastern University · P01 · FY2024 · DA
Development of GABABeta Receptor Compounds for Nicotine Dependence
$1,443,954Athina Markou · University Of California, San Diego · U19 · FY2010 · DA
Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse
$1,443,494David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA
Drugs On Learned & Spontaneous Behavior Of Experimental Animals
$1,442,458Steven R Goldberg · National Institute On Drug Abuse · Z01 · FY2007 · DA
Funding for MTA study (NIMH) - Irvine
$1,441,442Tim Wigal · University Of California-Irvine · N01 · FY2010 · DA
Neuron-Specific Candidate Gene Expression and Adolescent Vulnerability to Smoking
$1,441,300Burt M Sharp · University Of Tennessee Health Sci Ctr · RC2 · FY2009 · DA
Project-004
$1,440,775Kimberly Page · University Of New Mexico Health Scis Ctr · UG1 · FY2023 · DA
Early Environments and Genetic Effects on Alcohol Abuse and Associated Behavior
$1,439,953Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,439,808Kuan Wang · National Institute Of Mental Health · ZIA · FY2015 · MH
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$1,439,654Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2015 · DA
Behavioral Health Solutions: An Online Training Program for Evidence-Based Treatm
$1,439,478Kimberlee Jean Trudeau · Inflexxion, Inc. · R44 · FY2013 · DA
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain
$1,439,283James Jeffrey Sahn · 4e Therapeutics Inc. · U44 · FY2021 · NS
Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA)
$1,439,041Christopher J Evans · University Of California Los Angeles · P50 · FY2012 · DA
NDA-Enabling Phase I Lofexidine Program
$1,438,532James Alvan Longstreth · Us Worldmeds, Llc · U01 · FY2014 · DA
Endocannabinoid Active Sites as Therapeutic Targets
$1,438,465Alexandros Makriyannis · Northeastern University · P01 · FY2025 · DA
Alcohol and HIV: Biobehavioral Interactions and Intervention
$1,438,104Peter M. Monti · Brown University · P01 · FY2012 · AA
A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use
$1,437,329Gregory Scherrer · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DA
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,436,762Kuan Wang · National Institute Of Mental Health · ZIA · FY2016 · MH
Innovative Approaches for Cocaine Pharmacotherapy
$1,435,507Helen M Pettinati · University Of Pennsylvania · P50 · FY2012 · DA